Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -254,796 | -116,583 | -417,320 | -308,994 | -197,833 |
| Depreciation Amortization | 33,187 | 16,217 | 35,860 | 19,594 | 10,586 |
| Accounts payable and accrued liabilities | -869 | 668 | 8,000 | 7,563 | 6,535 |
| Other Working Capital | 36,729 | 27,670 | -8,001 | -1,411 | -8,791 |
| Other Operating Activity | 21,666 | -12,282 | 43,952 | 36,466 | 23,321 |
| Operating Cash Flow | $-164,083 | $-84,310 | $-337,509 | $-246,782 | $-166,182 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -236 | -158 | -500 | -537 | -550 |
| PPE Investments | -16,954 | -8,428 | -78,162 | -59,231 | -43,296 |
| Purchase Of Investment | N/A | N/A | -1,000 | -1,000 | -1,000 |
| Sale Of Investment | 102 | 102 | 128,188 | 128,188 | 113,434 |
| Purchase Sale Intangibles | N/A | N/A | -21,229 | -21,229 | -21,229 |
| Other Investing Activity | 0 | 0 | -21,229 | -21,229 | -21,229 |
| Investing Cash Flow | $-17,088 | $-8,484 | $27,297 | $46,191 | $47,359 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 59,700 | 29,850 | 174,125 | 124,375 | N/A |
| Debt Repayment | -38 | -19 | -58 | -40 | 0 |
| Common Stock Issued | 61,055 | 47,414 | 60,501 | 74 | 74 |
| Other Financing Activity | -417 | -357 | -955 | -736 | -387 |
| Financing Cash Flow | $120,300 | $76,888 | $233,613 | $123,673 | $-313 |
| Exchange Rate Effect | -264 | -254 | 284 | 123 | 80 |
| Beginning Cash Position | 104,965 | 104,965 | 181,280 | 181,280 | 181,280 |
| End Cash Position | 43,830 | 88,805 | 104,965 | 104,485 | 62,224 |
| Net Cash Flow | $-61,135 | $-16,160 | $-76,315 | $-76,795 | $-119,056 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164,083 | -84,310 | -337,509 | -246,782 | -166,182 |
| Capital Expenditure | -16,954 | -8,428 | -78,162 | -59,231 | -43,296 |
| Free Cash Flow | -181,037 | -92,738 | -415,671 | -306,013 | -209,478 |